ACTU - Actuate Therapeutics Inc.
2.86
-0.340 -11.888%
Share volume: 83,288
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$3.20
-0.34
-0.11%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 09-24-2024 | 11-13-2024 | 03-13-2025 | 05-15-2025 | 11-13-2025 | |
| Assets | ||||||
| Total Assets | 1.731 M | 14.263 M | 9.318 M | 4.483 M | 17.714 M | |
| Current Assets | 549.687 K | 14.263 M | 9.208 M | 4.249 M | 17.444 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 351.709 K | 13.523 M | 8.642 M | 3.889 M | 16.925 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 1.181 M | 0.000 | 110.548 K | 234.475 K | 269.934 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 1.731 M | 14.263 M | 9.318 M | 4.483 M | 17.714 M | |
| Total liabilities | 21.809 M | 8.904 M | 9.214 M | 9.571 M | 6.778 M | |
| Total current liabilities | 20.073 M | 8.497 M | 8.803 M | 9.154 M | 6.373 M | |
| Accounts Payable | 5.893 M | 2.330 M | 1.921 M | 2.644 M | 1.245 M | |
| Other liabilities | 1.736 M | 406.683 K | 411.759 K | 416.822 K | 404.991 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.736 M | 406.683 K | 411.759 K | 416.822 K | 404.991 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -114.257 M | 5.359 M | 104.186 K | -5.088 M | 10.936 M | |
| Common stock | 5.706 M | 131.292 M | 132.484 M | 133.609 M | 160.990 M | |
| Retained earnings | -119.963 M | -125.934 M | -132.380 M | -138.697 M | -150.054 M |